Stay updated on Benralizumab in Chronic Urticaria Clinical Trial

Sign up to get notified when there's something new on the Benralizumab in Chronic Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Benralizumab in Chronic Urticaria Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The NIH site-wide announcement about its website transition and use of “Super Intelligence” terminology is no longer displayed.
    Difference
    1%
    Check dated 2026-11-08T02:34:29.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer’s site revision label advanced from v3.7.2 to v3.8.0 while the page remained a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T22:27:21.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-24T22:27:03.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T22:28:32.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T22:18:31.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now returns a 403 Forbidden error instead of showing the study content, replacing the typical study details with an error message and site footer. This prevents users from viewing trial information and contact details.
    Difference
    20%
    Check dated 2026-09-19T20:40:34.000Z thumbnail image

Stay in the know with updates to Benralizumab in Chronic Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Benralizumab in Chronic Urticaria Clinical Trial page.